A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/454 (2006.01) A61K 31/44 (2006.01) A61P 25/02 (2006.01) A61P 29/00 (2006.01)
Patent
CA 2700910
The present application describes a method of treating conditions treatable with a CB2 cannabinoid receptor agonist with reduced CB1- mediated side effects using a combination therapy comprising a CB2 agonist and a CB1 ligand, which can be a CB1 antagonist or a CB1 inverse agonist.
La présente invention porte sur un procédé de traitement d'états pathologiques pouvant être traités par un agoniste des récepteurs cannabinoïdes CB2 avec des effets secondaires à médiation par CB1 réduits à l'aide d'une polythérapie incluant un agoniste de CB2 et un ligand de CB1 qui peuvent être un antagoniste de CB1 ou un agoniste inverse de CB1.
Abbott Laboratories
Torys Llp
LandOfFree
Combination therapy for reducing side effects using... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination therapy for reducing side effects using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy for reducing side effects using... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1947920